BlackBerry Limited (BB) 10-Q 27 Sep 24 2025 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Aug. 31, 2024	Sep. 24, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Aug. 31, 2024
Document Transition Report	false
Entity File Number	001-38232
Entity Registrant Name	BlackBerry Limited
Entity Incorporation, State or Country Code	Z4
Entity Tax Identification Number	98-0164408
Entity Address, Address Line One	2200 University Ave East
Entity Address, City or Town	Waterloo
Entity Address, State or Province	ON
Entity Address, Country	CA
Entity Address, Postal Zip Code	N2K 0A7
City Area Code	(519)
Local Phone Number	888-7465
Title of 12(g) Security	Common Shares
Trading Symbol	BB
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		590,727,996
Amendment Flag	false
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q2
Entity Central Index Key	0001070235
Current Fiscal Year End Date	--02-28

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Aug. 31, 2024	Feb. 29, 2024
Current
Cash and cash equivalents (note 2)	$ 171	$ 175
Short-term Investments	40	62
Accounts Receivable, after Allowance for Credit Loss, Current	150	199
Other receivables (note 3)	21	21
Income taxes receivable	4	4
Other current assets (note 3)	52	47
Assets, Current, Total	438	508
Restricted cash and cash equivalents (note 2)	17	25
Long-term investments (note 2)	37	36
Other long-term assets (note 3)	59	57
Operating Lease, Right-of-Use Asset	32	32
Property, plant and equipment, net (note 3)	17	21
Intangible assets, net (note 3)	136	154
Goodwill (note 3)	563	562
Assets	1,299	1,395
Current
Accounts payable	7	17
Accrued liabilities (note 3)	109	117
Income taxes payable (note 4)	28	28
Deferred revenue, current (note 10)	161	194
Total current liabilities	305	356
Deferred revenue, non-current (note 10)	28	28
Operating lease liabilities	38	38
Other long-term liabilities	1	3
Long-term notes (note 5)	195	194
Total liabilities	567	619
Capital stock and additional paid-in capital
Preferred shares: authorized unlimited number of non-voting, cumulative, redeemable and retractable	0	0
Common shares: authorized unlimited number of non-voting, redeemable, retractable Class A common shares and unlimited number of voting common shares Issued - 590,727,996 voting common shares (February 29, 2024 - 589,232,539)	2,964	2,948
Deficit	(2,219)	(2,158)
Accumulated other comprehensive loss (note 8)	(13)	(14)
Total shareholders' equity	732	776
Total liabilities and shareholders' equity	$ 1,299	$ 1,395
Common issued (in shares)	590,727,996	589,232,539
Common outstanding (in shares)	590,727,996	589,232,539

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Sep. 24, 2024	Aug. 31, 2024	Feb. 29, 2024	Feb. 28, 2023
Statement of Financial Position [Abstract]
Entity Common Stock, Shares Outstanding	590,727,996
Common outstanding (in shares)		590,727,996	589,232,539
Common issued (in shares)		590,727,996	589,232,539
Accounts Receivable, Allowance for Credit Loss		$ 6	$ 6	$ 1

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Equity - USD ($) $ in Millions	Total	Capital Stock and Additional Paid-in Capital	Deficit	Accumulated Other Comprehensive Loss
Beginning Balance at Feb. 28, 2023	$ 857	$ 2,909	$ (2,028)	$ (24)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(53)		(53)
Other comprehensive income (loss)	3			3
Stock-based compensation	20	20
Employee share purchase plan	2	2
Ending Balance at Aug. 31, 2023	829	2,931	(2,081)	(21)
Beginning Balance at May. 31, 2023	859	2,920	(2,039)	(22)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(42)		(42)
Other comprehensive income (loss)	1			1
Stock-based compensation	11	11
Ending Balance at Aug. 31, 2023	829	2,931	(2,081)	(21)
Beginning Balance at Feb. 29, 2024	776	2,948	(2,158)	(14)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(61)		(61)
Other comprehensive income (loss)	1			1
Stock-based compensation	15	15
Employee share purchase plan	1	1
Ending Balance at Aug. 31, 2024	732	2,964	(2,219)	(13)
Beginning Balance at May. 31, 2024	742	2,957	(2,200)	(15)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(19)		(19)
Other comprehensive income (loss)	2			2
Stock-based compensation	7	7
Ending Balance at Aug. 31, 2024	$ 732	$ 2,964	$ (2,219)	$ (13)

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Revenue
Revenues	$ 145	$ 132	$ 289	$ 505
Cost of sales
Cost of sales	51	47	99	241
Gross margin	94	85	190	264
Operating expenses
Research and development	37	50	79	104
Selling and Marketing Expense	34	43	72	88
General and Administrative Expense	33	30	73	84
Amortization	11	14	23	29
Impairment of long-lived assets (note 2)	0	1	3	1
Debentures fair value adjustment	0	(6)	0	16
Total operating expenses	115	132	250	322
Operating loss	(21)	(47)	(60)	(58)
Investment income, net (note 2 and note 5)	3	7	8	10
Loss before income taxes	(18)	(40)	(52)	(48)
Provision for income taxes (note 4)	1	2	9	5
Net loss	$ (19)	$ (42)	$ (61)	$ (53)
Loss per share (note 7)
Earnings (Loss) Per Share, Basic (in usd per share)	$ (0.03)	$ (0.07)	$ (0.10)	$ (0.09)
Earnings (Loss) Per Share, Diluted (in usd per share)	$ (0.03)	$ (0.07)	$ (0.10)	$ (0.09)

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (19)	$ (42)	$ (61)	$ (53)
Other comprehensive income (loss)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax	0	0	0	1
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	2	1	1	2
Other comprehensive income	2	1	1	3
Comprehensive loss	$ (17)	$ (41)	$ (60)	$ (50)

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Statement of Comprehensive Income [Abstract]
OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax	$ 0	$ 0	$ 0	$ 0
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, Unrealized Gain (Loss) Arising During Period, Tax	0	0	0	0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax	$ 0	$ 0	$ 0	$ 0

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Cash flows from operating activities
Net loss	$ (61)	$ (53)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Amortization	26	32
Stock-based compensation	15	20
Impairment of long-lived assets (note 2)	3	1
Intellectual property disposed of by sale	0	147
Debentures fair value adjustment	0	16
Operating leases	(4)	(5)
Other	(2)	0
Net changes in working capital items
Accounts receivable, net of allowance	49	(7)
Other receivables	0	4
Income taxes receivable	0	(2)
Other assets	(6)	(61)
Accounts payable	(10)	(6)
Accrued liabilities	(5)	(24)
Income taxes payable	0	1
Deferred revenue	(33)	(20)
Net cash provided by (used in) operating activities	(28)	43
Cash flows from investing activities
Acquisition of long-term investments	0	1
Acquisition of property, plant and equipment	(3)	(3)
Acquisition of intangible assets	(4)	(10)
Acquisition of short-term investments	72	92
Proceeds on sale or maturity of short-term investments	94	182
Net cash provided by investing activities	15	76
Cash flows from financing activities
Issuance of common shares	1	2
Net cash provided by financing activities	1	2
Net increase (decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents during the period	(12)	121
Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of period	200	322
Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period	$ 188	$ 443

Blackberry Limited and Summary

Blackberry Limited and Summary of Significant Accounting Policies and Critical Accounting Estimates	3 Months Ended	6 Months Ended
	Aug. 31, 2024	Aug. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of Significant Accounting Policies and Critical Accounting Estimates	1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND CRITICAL ACCOUNTING ESTIMATES Basis of Presentation and Preparation These interim consolidated financial statements have been prepared by management in accordance with United States generally accepted accounting principles (“U.S. GAAP”). They do not include all of the disclosures required by U.S. GAAP for annual financial statements and should be read in conjunction with the audited consolidated financial statements of BlackBerry Limited (the “Company”) for the year ended February 29, 2024 (the “Annual Financial Statements”), which have been prepared in accordance with U.S. GAAP. In the opinion of management, all normal recurring adjustments considered necessary for fair presentation have been included in these interim consolidated financial statements. Operating results for the three and six months ended August 31, 2024 are not necessarily indicative of the results that may be expected for the full year ending February 28, 2025. The consolidated balance sheet at February 29, 2024 was derived from the audited Annual Financial Statements but does not contain all of the footnote disclosures from the Annual Financial Statements. The preparation of the consolidated financial statements requires management to make estimates and assumptions with respect to the reported amounts of assets, liabilities, revenue and expenses and the disclosure of contingent assets and liabilities. Actual results could differ from these estimates and any such differences may be material to the Company’s consolidated financial statements. Certain of the comparative figures have been reclassified to conform to the current year’s presentation. The Company is organized and managed as three reportable operating segments: Cybersecurity, IoT (collectively, “Software & Services”), and Licensing, as further discussed in Note 10. Significant Accounting Policies and Critical Accounting Estimates There have been no material changes to the Company’s accounting policies or critical accounting estimates from those described in the Annual Financial Statements. Accounting Standards Adopted During Fiscal 2025 In November 2023, the Financial Accounting Standards Board (the “FASB”) issued ASU 2023-07 on the topic of segment reporting. The standard requires additional disclosures for segment reporting. These requirements include: (i) disclosure of significant expenses that are regularly provided to the Chief Operating Decision Maker (“CODM”) and included within each reported measure of segment profit or loss (collectively referred to as the “significant expense principle”); (ii) disclosure of an amount for other segment items (equal to the difference between segment revenue less segment expenses disclosed under the significant expense principle and each reported measure of segment profit or loss) by reportable segment and a description of their composition; (iii) annual disclosure of a reportable segment’s profit or loss and assets currently required by Topic 280 in interim periods; (iv) clarification that, if the CODM uses more than one measure of a segment's profit or loss in assessing segment performance and deciding how to allocate resources, a public entity may report those additional measures of segment profit or loss; (v) disclosure of the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources; and (vi) requiring a public entity that has a single reportable segment provide all the disclosures required by the amendments in this ASU, and all existing segment disclosures in Topic 280. The guidance is effective for annual periods beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The Company early adopted this guidance in the first quarter of fiscal 2025 and it did not have a material impact on its disclosures.
Adoption Pronouncements Not Yet Adopted		Accounting Pronouncements Not Yet Adopted In December 2023, the FASB issued ASU 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” on the topic of income taxes. The standard requires additional disclosure for income taxes. These requirements include: (i) requiring a public entity to disclose specific categories in the rate reconciliation; (ii) disclosure of additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5% of the amount computed by multiplying pretax income or loss by the applicable statutory income tax rate); (iii) annual disclosure of the amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes; (iv) annual disclosure of the amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5% of total income taxes paid (net of refunds received); (v) annual disclosure of income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign; and (vi) annual disclosure of income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. For public entities, the guidance is effective for annual periods beginning after December 15, 2024. The Company will adopt this guidance in fiscal 2026 and is in the process of evaluating the new requirements. As a result, the Company has not yet determined the impact this new ASU will have on its disclosures.

Fair Value Measurements, Cash,

Fair Value Measurements, Cash, Cash Equivalents and Investments	6 Months Ended
	Aug. 31, 2024
Cash and Cash Equivalents [Abstract]
Fair Value Measurements, Cash, Cash Equivalents and Investments	FAIR VALUE MEASUREMENTS, CASH, CASH EQUIVALENTS AND INVESTMENTS Fair Value The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use in pricing the asset or liability, such as inherent risk, non-performance risk and credit risk. The Company applies the following fair value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value into three levels: • Level 1 - Unadjusted quoted prices at the measurement date for identical assets or liabilities in active markets. • Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. • Level 3 - Significant unobservable inputs that are supported by little or no market activity. The fair value hierarchy also requires the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The Company’s cash and cash equivalents, accounts receivable, other receivables, accounts payable and accrued liabilities are carried at amounts that approximate their fair values (Level 2 measurement) due to their short maturities. Recurring Fair Value Measurements In determining the fair value of investments held, the Company primarily relies on an independent third-party valuator for the fair valuation of securities. The Company also reviews the inputs used in the valuation process and assesses the pricing of the securities for reasonableness after conducting its own internal collection of quoted prices from brokers. Fair values for all investment categories provided by the independent third-party valuator that are in excess of 0.5% from the fair values determined by the Company are communicated to the independent third-party valuator for consideration of reasonableness. The independent third-party valuator considers the information provided by the Company before determining whether a change in their original pricing is warranted. When the Company concludes that there is a significant financing component included within a contract with a customer due to timing differences between the fulfillment of certain performance obligations and the receipt of payment for those performance obligations, the Company determines the present value of the future consideration utilizing the discount rate that would be reflected in a separate financing transaction between the customer and the Company at contract inception based upon the credit characteristics of the customer receiving financing in the contract. For a description of how the fair value of the 2020 Debentures (as defined in Note 5) was determined, see the “Convertible debentures” accounting policies in Note 1 to the Annual Financial Statements. Non-Recurring Fair Value Measurements Upon the occurrence of certain events, the Company re-measures the fair value of non-marketable equity investments for which it utilizes the measurement alternative, and long-lived assets, including property, plant and equipment, operating lease ROU assets, intangible assets and goodwill if an impairment or observable price adjustment is recognized in the current period. Non-Marketable Equity Investments Measured Using the Measurement Alternative Non-marketable equity investments measured using the measurement alternative include investments in privately held companies without readily determinable fair values in which the Company does not own a controlling interest or have significant influence. The estimation of fair value used in the fair value measurements required the use of significant unobservable inputs, and as a result, the fair value measurements were classified as Level 3. Impairment of Long-Lived Assets During the three and six months ended August 31, 2024, the Company exited certain leased facilities and recorded a pre-tax and after-tax impairment charge of nil and $3 million, respectively, related to the operating lease right-of-use (“ROU”) assets and property, plant and equipment associated with those facilities (three and six months ended August 31, 2023 - $1 million). The impairment was determined by comparing the fair value of the impacted ROU asset to the carrying value of the asset as of the impairment measurement date, as required under ASC Topic 360, Property, Plant, and Equipment, using Level 3 inputs. The fair value of the ROU asset was based on the estimated sublease income for certain facilities taking into consideration the estimated time period it will take to obtain a sublessor, the applicable discount rate and the sublease rate, which are considered unobservable inputs. The Company conducts an evaluation of the related liabilities and expenses and revises its assumptions and estimates as appropriate as new or updated information becomes available. The fair value measurement of ROU impaired assets is classified as Level 3. Cash, Cash Equivalents and Investments The components of cash, cash equivalents and investments by fair value level as at August 31, 2024 were as follows: Cost Basis (1) Unrealized Unrealized Fair Value Cash and Short-term Long-term Restricted Cash and Cash Equivalents Bank balances $ 65 $ — $ — $ 65 $ 65 $ — $ — $ — Other investments 28 6 — 34 — — 34 — 93 6 — 99 65 — 34 — Level 1: Equity securities 10 — (10) — — — — — Level 2: Term deposits, and certificates of deposits 23 — — 23 10 — — 13 Bearer deposit notes 31 — — 31 29 2 — — Commercial paper 44 — — 44 18 26 — — Non-U.S. promissory notes 42 — — 42 30 12 — — U.S. treasury bills 23 — — 23 19 — — 4 163 — — 163 106 40 — 17 Level 3: Other investments 2 1 — 3 — — 3 — $ 268 $ 7 $ (10) $ 265 $ 171 $ 40 $ 37 $ 17 ______________________________ (1) Cost basis for other investments includes the effect of returns of capital and impairment. The components of cash, cash equivalents and investments by fair value level as at February 29, 2024 were as follows: Cost Basis (1) Unrealized Unrealized Fair Value Cash and Short-term Long-term Restricted Cash and Cash Equivalents Bank balances $ 96 $ — $ — $ 96 $ 96 $ — $ — $ — Other investments 30 6 — 36 — — 36 — 126 6 — 132 96 — 36 — Level 1: Equity securities 10 — (10) — — — — — Level 2: Term deposits, and certificates of deposits 21 — — 21 — — — 21 Bearer deposit notes 53 — — 53 28 25 — — Commercial paper 47 — — 47 15 32 — — Non-U.S. promissory notes 35 — — 35 30 5 — — U.S. treasury bills 10 — — 10 6 — — 4 166 — — 166 79 62 — 25 $ 302 $ 6 $ (10) $ 298 $ 175 $ 62 $ 36 $ 25 ______________________________ (1) Cost basis for other investments includes the effect of returns of capital and impairment. As at August 31, 2024, the Company had non-marketable equity investments without readily determinable fair value of $37 million (February 29, 2024 - $36 million). During the three and six months ended August 31, 2024, the Company recorded an upward adjustment of nil and $1 million, respectively, to the carrying value of a certain non-marketable equity investment without readily determinable fair value resulting from observable price changes in orderly transactions for identical or similar securities which have been included in investment income, net on the Company’s consolidated statements of operations. As of August 31, 2024, the Company has recorded a cumulative impairment of $3 million to the carrying value of certain other non-marketable equity investments without readily determinable fair value (February 29, 2024 - $3 million). There were no realized gains or losses on available-for-sale securities for the three and six months ended August 31, 2024 and August 31, 2023. The Company has restricted cash and cash equivalents, consisting of cash and securities pledged as collateral to major banking partners in support of the Company’s requirements for letters of credit. These letters of credit support certain leasing arrangements entered into in the ordinary course of business. The letters of credit are for terms ranging from one four The following table provides a reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents as at August 31, 2024 and February 29, 2024 from the consolidated balance sheets to the consolidated statements of cash flows: As at August 31, 2024 February 29, 2024 Cash and cash equivalents $ 171 $ 175 Restricted cash and cash equivalents 17 25 Total cash, cash equivalents, restricted cash, and restricted cash equivalents presented in the consolidated statements of cash flows $ 188 $ 200 The contractual maturities of available-for-sale investments as at August 31, 2024 and February 29, 2024 were as follows: As at August 31, 2024 February 29, 2024 Cost Basis Fair Value Cost Basis Fair Value Due in one year or less $ 163 $ 163 $ 166 $ 166 No fixed maturity 10 — 10 — $ 173 $ 163 $ 176 $ 166

Consolidated Balance Sheets Det

Consolidated Balance Sheets Details	6 Months Ended
	Aug. 31, 2024
Balance Sheet Related Disclosures [Abstract]
Consolidated Balance Sheet Details	3. CONSOLIDATED BALANCE SHEET DETAILS Accounts Receivable, Net of Allowance The current estimated credit losses (“CECL”) for accounts receivable as at August 31, 2024 were $6 million (February 29, 2024 - $6 million). The Company also has long-term accounts receivable included in Other Long-term Assets. The CECL for long-term accounts receivable is estimated using the probability of default method and the default exposure due to limited historical information. The exposure of default is represented by the assets’ amortized carrying amount at the reporting date. The following table sets forth the activity in the Company’s allowance for credit losses: Carrying Amount Beginning balance as of February 28, 2023 $ 1 Prior period provision for expected credit losses 5 Ending balance of the allowance for credit loss as at February 29, 2024 6 Current period recovery for expected credit losses — Ending balance of the allowance for credit loss as at August 31, 2024 $ 6 The allowance for credit losses as at August 31, 2024 consists of $1 million (February 29, 2024 - $1 million) relating to CECL estimated based on days past due and region and $5 million (February 29, 2024 - $5 million) relating to specific customers that were evaluated separately. There was one customer that comprised more than 10% of accounts receivable as at August 31, 2024 (February 29, 2024 - two customers comprised more than 10%). Other Receivables As at August 31, 2024 and February 29, 2024, other receivables included items such as other receivables related to intellectual property sold in fiscal 2024, see Note 10 under the heading “Patent Sale”, and claims filed with the Ministry of Innovation, Science and Economic Development Canada relating to its Strategic Innovation Fund program’s investment in BlackBerry QNX, among other items, none of which were greater than 5% of the current assets balance. Other Current Assets As at August 31, 2024 and February 29, 2024, other current assets included the current portion of deferred commissions and prepaid expenses, among other items, none of which were greater than 5% of the current assets balance as at the balance sheet dates. Property, Plant and Equipment, Net Property, plant and equipment comprised the following: As at August 31, 2024 February 29, 2024 Cost BlackBerry operations and other information technology $ 85 $ 85 Leasehold improvements and other 12 15 Furniture and fixtures 5 6 Manufacturing, repair and research and development equipment 2 3 104 109 Accumulated amortization 87 88 Net book value $ 17 $ 21 Intangible Assets, Net Intangible assets comprised the following: As at August 31, 2024 Cost Accumulated Net Book Acquired technology $ 900 $ 855 $ 45 Other acquired intangibles 386 341 45 Intellectual property 111 65 46 $ 1,397 $ 1,261 $ 136 As at February 29, 2024 Cost Accumulated Net Book Acquired technology $ 900 $ 846 $ 54 Other acquired intangibles 386 334 52 Intellectual property 111 63 48 $ 1,397 $ 1,243 $ 154 For the six months ended August 31, 2024, amortization expense related to intangible assets amounted to $22 million (six months ended August 31, 2023 - $26 million). Total additions to intangible assets for the six months ended August 31, 2024 amounted to $4 million (six months ended August 31, 2023 - $10 million). During the six months ended August 31, 2024, additions to intangible assets primarily consisted of payments for intellectual property relating to patent maintenance, registration and license fees. Based on the carrying value of the identified intangible assets as at August 31, 2024, and assuming no subsequent impairment of the underlying assets, the annual amortization expense for the remainder of fiscal 2025 and each of the five succeeding years is expected to be as follows: fiscal 2025 - $21 million; fiscal 2026 - $37 million; fiscal 2027 - $32 million; fiscal 2028 - $18 million; fiscal 2029 - $6 million and fiscal 2030 - $3 million. Goodwill Changes to the carrying amount of goodwill during the six months ended August 31, 2024 were as follows: Carrying Amount Carrying amount as at February 28, 2023 $ 595 Goodwill impairment charge (35) Effect of foreign exchange on non-U.S. dollar denominated goodwill 2 Carrying amount as at February 29, 2024 562 Effect of foreign exchange on non-U.S. dollar denominated goodwill 1 Carrying amount as at August 31, 2024 $ 563 Other Long-term Assets As at August 31, 2024 and February 29, 2024, other long-term assets included long-term receivables related to intellectual property sold in fiscal 2024, see Note 10 under the heading “Patent Sale”, other long-term receivables, and the long-term portion of deferred commission, among other items, none of which were greater than 5% of the total assets balance. Accrued Liabilities Accrued liabilities is comprised of the following: As at August 31, 2024 February 29, 2024 Variable incentive accrual $ 21 $ 15 Operating lease liabilities, current 17 20 Restructuring program liabilities, current portion 7 20 Other 64 62 $ 109 $ 117 As at August 31, 2024 and February 29, 2024, other accrued liabilities included accrued director fees, accrued vendor liabilities, payroll withholding taxes and accrued royalties, among other items, none of which were greater than 5% of the current liabilities balance in any of the periods presented.
Restructuring and Integration	Restructuring During fiscal 2023 and fiscal 2024, the Company commenced restructuring programs with the objectives of reducing its annual costs and expenses relating to the Cybersecurity business, and later significantly separating and streamlining the Company’s centralized corporate functions into Cybersecurity and IoT specific teams such that the businesses may operate quasi-independently and on a profitable and cash flow positive basis. The reduction of overall Company costs had included and will continue to include rationalizing and streamlining existing central administrative functions, right-sizing cost structures within both business units including R&D and outsourced contracting, changes to overall product portfolio offerings and geographies the Company operates in and optimizing related support functions and organizational structure. Other charges and cash costs may occur as programs are implemented or changes are completed. The following table sets forth the activity in the Company’s restructuring program liabilities: Employee Facilities Total Balance as at February 28, 2023 2 1 3 Charges incurred 31 6 37 Cash payments made (16) (3) (19) Balance as at February 29, 2024 17 4 21 Charges incurred 7 2 9 Cash payments made (20) (2) (22) Balance as at August 31, 2024 $ 4 $ 4 $ 8 Current portion $ 4 $ 3 $ 7 Long-term portion — 1 1 $ 4 $ 4 $ 8 The long-term portion of the restructuring liabilities is recorded at present value, determined by measuring the remaining payments at present value using an effective interest rate of 5.3%, and the Company recorded interest expense over time to arrive at the total face value of the remaining payments. General and administrative

Income Taxes

Income Taxes	6 Months Ended
	Aug. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES For the six months ended August 31, 2024, the Company’s net effective income tax expense rate was approximately 17% compared to a net effective income tax expense rate of 10% for the six months ended August 31, 2023. The Company’s income tax rate reflects the change in unrecognized income tax benefit, if any, and the fact that the Company has a significant valuation allowance against its deferred income tax assets; in particular, any change in loss carry forwards or research and development credits, amongst other items, is offset by a corresponding adjustment of the valuation allowance. The Company’s net effective income tax rate also reflects the geographic mix of earnings in jurisdictions with different income tax rates. The Company’s total unrecognized income tax benefits as at August 31, 2024 were $20 million (February 29, 2024 - $20 million). As at August 31, 2024, $20 million of the unrecognized income tax benefits have been netted against deferred income tax assets and nil has been recorded within income taxes payable on the Company’s consolidated balance sheets. The Company is subject to ongoing examination by tax authorities in certain jurisdictions in which it operates. The Company regularly assesses the status of these examinations and the potential for adverse outcomes to determine the adequacy of the provision for income taxes as well as the provisions for indirect and other taxes and related penalties and interest. While the final resolution of audits is uncertain, the Company believes the ultimate resolution of these audits will not have a material adverse effect on its consolidated financial position, liquidity or results of operations.

Debentures

Debentures	6 Months Ended
	Aug. 31, 2024
Debt Disclosure [Abstract]
Debentures	DEBENTURES 3.00% Convertible Senior Notes On January 29, 2024, the Company issued $200 million aggregate principal amount of 3.00% senior convertible unsecured notes (the “Notes” and, collectively with the 2020 Debentures, the “Debentures”) in an offering to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended. The Notes are due on February 15, 2029 unless earlier converted, redeemed, or repurchased. Each $1,000 principal amount of the Notes is convertible into 257.5826 common shares of the Company based on the initial conversion rate, for a total of 52 million common shares at a price of $3.88 per share, subject to adjustments. Prior to the close of business on the business day immediately preceding November 15, 2028, the Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding February 15, 2029. The Company may satisfy any conversions of the Notes by paying or delivering, as the case may be, cash, its common shares or a combination of cash and its common shares, at the Company’s election (or, in the case of any Notes called for redemption that are converted during the related redemption period, solely its common shares). Covenants associated with the Notes include general corporate maintenance, existence and reporting requirements. The Notes bear interest at a rate of 3.00% per annum, payable semi-annually in arrears on February 15 and August 15 of each year, beginning on August 15, 2024. The Company had recorded the Notes, including the debt itself and all embedded derivatives, at cost less debt issuance costs of $6 million and presents the Notes as a single hybrid financial instrument. No portion of the embedded derivatives required bifurcation from the host debt contract. The following table summarizes the change in the Notes for the six months ended August 31, 2024: Carrying Amount Balance as at February 29, 2024 $ 194 Amortization of debt issuance costs 1 Balance as at August 31, 2024 $ 195 2020 Debentures On September 1, 2020, Hamblin Watsa Investment Counsel Ltd., in its capacity as investment manager of Fairfax Financial Holdings Limited (“Fairfax”), and another institutional investor invested in the Company through a $365 million private placement of debentures (the “2020 Debentures”). The 2020 Debentures matured on November 13, 2023. Due to the conversion option and other embedded derivatives within the 2020 Debentures, the Company elected to record the 2020 Debentures, including the debt itself and all embedded derivatives, at fair value and presented the 2020 Debentures as a single hybrid financial instrument. No portion of the fair value of the 2020 Debentures was recorded as equity. Each period, the fair value of the 2020 Debentures was recalculated and resulting gains and losses from the change in fair value of the 2020 Debentures associated with non-credit components were recognized in income, while the change in fair value associated with credit components was recognized in accumulated other comprehensive loss (“AOCL”). The fair value of the 2020 Debentures was determined using the significant Level 2 inputs interest rate curves, the market price and volatility of the Company’s listed common shares, and the significant Level 3 inputs related to credit spread and the implied discount of the 2020 Debentures at issuance. The following table shows the impact of the changes in fair value of the Debentures for the three and six months ended August 31, 2024 and August 31, 2023: Three Months Ended Six Months Ended August 31, 2024 August 31, 2023 August 31, 2024 August 31, 2023 Income (charge) associated with the change in fair value from non-credit components recorded in the consolidated statements of operations $ — $ 6 $ — $ (16) Total decrease (increase) in the fair value of the 2020 Debentures $ — $ 6 $ — $ (16) For the three and six months ended August 31, 2024, the Company recorded interest expense related to the Debentures of $2 million and $3 million, respectively, which has been included in investment income, net on the Company’s consolidated statements of operations (three and six months ended August 31, 2023 - $2 million and $3 million). Fairfax, a related party under U.S. GAAP due to its beneficial ownership of common shares in the Company after taking into account potential conversion of the 2020 Debentures, owned $330 million principal amount of the 2020 Debentures. As such, the payment of interest on the 2020 Debentures to Fairfax represented a related party transaction.

Capital Stock

Capital Stock	6 Months Ended
	Aug. 31, 2024
Equity [Abstract]
Capital Stock	CAPITAL STOCK The following details the changes in issued and outstanding common shares for the six months ended August 31, 2024: Capital Stock and Stock Amount Common shares outstanding as at February 29, 2024 589,233 $ 2,948 Common shares issued for restricted share unit settlements 940 — Stock-based compensation — 15 Common shares issued for employee share purchase plan 555 1 Common shares outstanding as at August 31, 2024 590,728 $ 2,964 The Company had 591 million voting common shares outstanding, 0.2 million options to purchase voting common shares, 18 million RSUs and 1 million DSUs outstanding as at September 24, 2024. In addition, 51.5 million common shares are issuable upon conversion in full of the Notes as described in Note 5.

Earnings (Loss) Per Share

Earnings (Loss) Per Share	6 Months Ended
	Aug. 31, 2024
Earnings Per Share [Abstract]
Earnings (Loss) Per Share	LOSS PER SHARE The following table sets forth the computation of basic and diluted loss per share: Three Months Ended Six Months Ended August 31, 2024 August 31, 2023 August 31, 2024 August 31, 2023 Net loss for basic and diluted loss per share available to common shareholders $ (19) $ (42) $ (61) $ (53) Weighted average number of shares outstanding (000’s) - basic and diluted (1)(2) 590,549 583,524 590,188 583,171 Loss per share - reported Basic $ (0.03) $ (0.07) $ (0.10) $ (0.09) Diluted $ (0.03) $ (0.07) $ (0.10) $ (0.09) ______________________________ (1) The Company has not presented the dilutive effect of the Notes or 2020 Debentures using the if-converted method in the calculation of diluted loss per share for the three and six months ended August 31, 2024 and August 31, 2023, as to do so would be antidilutive. See Note 5 for details on the Notes and 2020 Debentures. (2) The Company has not presented the dilutive effect of in-the-money options and RSUs that will be settled upon vesting by the issuance of new common shares in the calculation of diluted loss per share for the three and six months ended August 31, 2024 and August 31, 2023, as to do so would be antidilutive.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	6 Months Ended
	Aug. 31, 2024
Equity [Abstract]
Accumulated Other Comprehensive Loss	8. ACCUMULATED OTHER COMPREHENSIVE LOSS The changes in AOCL by component net of tax, for the three and six months ended August 31, 2024 and August 31, 2023 were as follows: Three Months Ended Six Months Ended August 31, 2024 August 31, 2023 August 31, 2024 August 31, 2023 Cash Flow Hedges Balance, beginning of period $ — $ — $ — $ (1) Amounts reclassified from AOCL into net loss — — — 1 Accumulated net unrealized gains on derivative instruments designated as cash flow hedges $ — $ — $ — $ — Foreign Currency Cumulative Translation Adjustment Balance, beginning of period $ (15) $ (15) $ (14) $ (16) Other comprehensive income 2 1 1 2 Foreign currency cumulative translation adjustment $ (13) $ (14) $ (13) $ (14) Change in Fair Value From Instrument-Specific Credit Risk On Debentures Change in fair value from instruments-specific credit risk on Debentures $ — $ (6) $ — $ (6) Other Post-Employment Benefit Obligations Actuarial losses associated with other post-employment benefit obligations $ — $ (1) $ — $ (1) Accumulated Other Comprehensive Loss, End of Period $ (13) $ (21) $ (13) $ (21)

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Aug. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	COMMITMENTS AND CONTINGENCIES (a) Letters of Credit The Company had $16 million in collateralized outstanding letters of credit in support of certain leasing arrangements entered into in the ordinary course of business as of August 31, 2024. See the discussion of restricted cash in Note 2. (b) Contingencies Litigation The Company is involved in litigation in the normal course of its business, both as a defendant and as a plaintiff. The Company is subject to a variety of claims (including claims related to patent infringement, purported class actions and other claims in the normal course of business) and may be subject to additional claims either directly or through indemnities against claims that it provides to certain of its partners and customers. In particular, the industry in which the Company competes has many participants that own, or claim to own, intellectual property, including participants that have been issued patents and may have filed patent applications or may obtain additional patents and proprietary rights for technologies similar to those used by the Company in its products. The Company has received, and may receive in the future, assertions and claims from third parties that the Company’s products infringe on their patents or other intellectual property rights. Litigation has been, and will likely continue to be, necessary to determine the scope, enforceability and validity of third-party proprietary rights or to establish the Company’s proprietary rights. Regardless of whether claims against the Company have merit, those claims could be time-consuming to evaluate and defend, result in costly litigation, divert management’s attention and resources and subject the Company to significant liabilities. Management reviews all of the relevant facts for each claim and applies judgment in evaluating the likelihood and, if applicable, the amount of any potential loss. Where a potential loss is considered probable and the amount is reasonably estimable, provisions for loss are made based on management’s assessment of the likely outcome. Where a range of loss can be reasonably estimated with no best estimate in the range, the Company records the minimum amount in the range. The Company does not provide for claims for which the outcome is not probable or claims for which the amount of the loss cannot be reasonably estimated. Any settlements or awards under such claims are provided for when reasonably determinable. As of August 31, 2024, there are no material claims outstanding for which the Company has assessed the potential loss as both probable to result and reasonably estimable; therefore, no accrual has been made. Further, there are claims outstanding for which the Company has assessed the potential loss as reasonably possible to result; however, an estimate of the amount of loss cannot reasonably be made. There are many reasons that the Company cannot make these assessments, including, among others, one or more of the following: the early stages of a proceeding does not require the claimant to specifically identify the patent claims that have allegedly been infringed or the products that are alleged to infringe; damages sought are unspecified, unsupportable, unexplained or uncertain; discovery has not been started or is incomplete; the facts that are in dispute are highly complex; the difficulty of assessing novel claims; the parties have not engaged in any meaningful settlement discussions; the possibility that other parties may share in any ultimate liability; and the often slow pace of litigation. The Company has included the following summaries of certain of its legal proceedings though they do not meet the test for accrual described above. Between October and December 2013, several purported class action lawsuits and one individual lawsuit were filed against the Company and certain of its former officers in various jurisdictions in the U.S. and Canada alleging that the Company and certain of its officers made materially false and misleading statements regarding the Company’s financial condition and business prospects and that certain of the Company’s financial statements contain material misstatements. The individual lawsuit was voluntarily dismissed and the consolidated U.S. class actions Stipulation of Settlement was executed effective June 7, 2022. On July 23, 2014, the plaintiff in the putative Ontario class action ( Swisscanto Fondsleitung AG v. BlackBerry Limited, et al. ) filed a motion for class certification and for leave to pursue statutory misrepresentation claims. On November 17, 2015, the Ontario Superior Court of Justice issued an order granting the plaintiffs’ motion for leave to file a statutory claim for misrepresentation. On December 2, 2015, the Company filed a notice of motion seeking leave to appeal this ruling. On November 15, 2018, the Court denied the Company’s motion for leave to appeal the order granting the plaintiffs leave to file a statutory claim for misrepresentation. On February 5, 2019, the Court entered an order certifying a class comprised persons (a) who purchased BlackBerry common shares between March 28, 2013, and September 20, 2013, and still held at least some of those shares as of September 20, 2013, and (b) who acquired those shares on a Canadian stock exchange or acquired those shares on any other stock exchange and were a resident of Canada when the shares were acquired. Notice of class certification was published on March 6, 2019. The Company filed its Statement of Defence on April 1, 2019. Discovery is proceeding and the Court has not set a trial date. On March 17, 2017, a putative employment class action was filed against the Company in the Ontario Superior Court of Justice ( Parker v. BlackBerry Limited ). The Statement of Claim alleges that actions the Company took when certain of its employees decided to accept offers of employment from Ford Motor Company of Canada amounted to a wrongful termination of the employees’ employment with the Company. The claim seeks (i) an unspecified quantum of statutory, contractual, or common law termination entitlements; (ii) punitive or breach of duty of good faith damages of CAD$20 million, or such other amount as the Court finds appropriate, (iii) pre- and post- judgment interest, (iv) attorneys’ fees and costs, and (v) such other relief as the Court deems just. The Court granted the plaintiffs’ motion to certify the class action on May 27, 2019. The Company commenced a motion for leave to appeal the certification order on June 11, 2019. The Court denied the motion for leave to appeal on September 17, 2019. The Company filed its Statement of Defence on December 19, 2019. The parties participated in a mediation on November 9, 2022, which did not result in an agreement. The Court has set a trial date of June 2, 2025, and scheduled a pre-trial conference on December 4, 2024. Discovery is proceeding. Other contingencies As at August 31, 2024, the Company has recognized $17 million (February 29, 2024 - $17 million) in funds from claims filed with the Ministry of Innovation, Science and Economic Development Canada relating to its Strategic Innovation Fund program’s investment in BlackBerry QNX. A portion of this amount may be repayable in the future under certain circumstances if certain terms and conditions are not met by the Company, which is not probable at this time. (c) Indemnifications The Company enters into certain agreements that contain indemnification provisions under which the Company could be subject to costs and damages, including in the event of an infringement claim against the Company or an indemnified third party. Such intellectual property infringement indemnification clauses are generally not subject to any dollar limits and remain in effect for the term of the Company’s agreements. To date, the Company has not encountered material costs as a result of such indemnifications.

Revenue and Segment Disclosures

Revenue and Segment Disclosures	6 Months Ended
	Aug. 31, 2024
Segment Reporting [Abstract]
Revenue and Segment Disclosures	REVENUE AND SEGMENT DISCLOSURES The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by the CODM for making decisions and assessing performance as a source of the Company’s reportable operating segments. The CODM, who is the CEO of the Company, makes decisions and assesses the performance of the Company using three operating segments. The CODM does not evaluate operating segments using discrete asset information. The Company does not specifically allocate assets to operating segments for internal reporting purposes. Segment Disclosures The Company is organized and managed as three operating segments: Cybersecurity, IoT, and Licensing. The following table shows information by operating segment for the three and six months ended August 31, 2024 and August 31, 2023: For the Three Months Ended Cybersecurity IoT Licensing Segment Totals August 31, August 31, August 31, August 31, 2024 2023 2024 2023 2024 2023 2024 2023 Segment revenue $ 87 $ 79 $ 55 $ 49 $ 3 $ 4 $ 145 $ 132 Segment cost of sales 39 36 10 8 1 2 50 46 Segment gross margin (1) $ 48 $ 43 $ 45 $ 41 $ 2 $ 2 $ 95 $ 86 For the Six Months Ended Cybersecurity IoT Licensing Segment Totals August 31, August 31, August 31, August 31, 2024 2023 2024 2023 2024 2023 2024 2023 Segment revenue $ 172 $ 172 $ 108 $ 94 $ 9 $ 239 $ 289 $ 505 Segment cost of sales 74 73 20 17 3 149 97 239 Segment gross margin (1) $ 98 $ 99 $ 88 $ 77 $ 6 $ 90 $ 192 $ 266 ______________________________ (1) A reconciliation of total segment gross margin to consolidated totals is set forth below. Cybersecurity consists of BlackBerry® UEM and Cylance® cybersecurity solutions, BlackBerry® AtHoc® and BlackBerry® SecuSUITE®. The Company’s Cylance AI and machine learning-based platform consists of CylanceENDPOINT™, CylanceMDR™, CylanceEDGE™ and other cybersecurity applications. The Company’s endpoint management platform includes BlackBerry® UEM, BlackBerry® Dynamics™, and BlackBerry® Workspaces solutions. Cybersecurity revenue is generated predominantly through software licenses, commonly bundled with support, maintenance and professional services. IoT consists of BlackBerry® QNX®, BlackBerry® Certicom®, BlackBerry Radar®, BlackBerry IVY® and other IoT applications. IoT revenue is generated predominantly through software licenses, commonly bundled with support, maintenance and professional services. Licensing consists of the Company’s intellectual property arrangements and settlement awards. The following table reconciles total segment gross margin for the three and six months ended August 31, 2024 and August 31, 2023 to the Company’s consolidated totals: Three Months Ended Six Months Ended August 31, 2024 August 31, 2023 August 31, 2024 August 31, 2023 Total segment gross margin $ 95 $ 86 192 $ 266 Adjustments (1) : Less: Stock compensation 1 1 2 2 Less: Research & development 37 50 79 104 Sales and marketing 34 43 72 88 General and administrative 33 30 73 84 Amortization 11 14 23 29 Impairment of long-lived assets — 1 3 1 Debentures fair value adjustment — (6) — 16 Investment income, net (3) (7) (8) (10) Loss before income taxes $ (18) $ (40) $ (52) $ (48) ______________________________ (1) The CODM reviews segment information on an adjusted basis, which excludes certain amounts as described below: Stock compensation expenses - Equity compensation is a non-cash expense and does not impact the ongoing operating decisions taken by the Company’s management. Patent Sale On May 11, 2023, the Company completed the sale of certain non-core patent assets to Malikie Innovations Limited for $170 million in cash on closing, an additional $30 million in fixed consideration due by no later than the third anniversary of closing and variable consideration in the form of future royalties in the aggregate amount of up to $700 million (the “Malikie Transaction”). Pursuant to the terms of the Malikie Transaction, the Company received a license back to the patents sold, which relate primarily to mobile devices, messaging and wireless networking. In the first quarter of fiscal 2024, the Company recognized revenue of $218 million and cost of sales of $147 million related to intellectual property sold. As at August 31, 2024, the remaining financing component on the patent sale was $8 million and will be recognized as interest income over the payment terms. The Company estimated variable consideration from future royalty revenues using an expected value method including inputs from both internal and external sources related to patent monetization activities and cash flows, and constrained the recognition of that variable consideration based on the Company’s accounting policies and critical accounting estimates as described in Note 1. The present value of variable consideration recognized as revenue was $23 million and the amount of variable consideration constrained was $210 million. The Company evaluates its conclusions as to whether the constraints are still applicable on an ongoing basis, and will make updates when it observes a sufficient amount of evidence that amounts of variable consideration are no longer subject to constraint or the estimated amount of variable consideration has changed. Revenue The Company disaggregates revenue from contracts with customers based on geographical regions, timing of revenue recognition, and the major product and service types, as discussed above in “Segment Disclosures”. The Company’s revenue, classified by major geographic region in which the Company’s customers are located, was as follows: Three Months Ended Six Months Ended August 31, 2024 August 31, 2023 August 31, 2024 August 31, 2023 North America (1) $ 69 $ 72 $ 137 $ 389 Europe, Middle East and Africa 47 39 94 76 Other regions 29 21 58 40 Total $ 145 $ 132 $ 289 $ 505 North America (1) 47.6 % 54.5 % 47.4 % 77.0 % Europe, Middle East and Africa 32.4 % 29.6 % 32.5 % 15.1 % Other regions 20.0 % 15.9 % 20.1 % 7.9 % Total 100.0 % 100.0 % 100.0 % 100.0 % ______________________________ (1) North America includes all revenue from the Company’s intellectual property arrangements, due to the global applicability of the patent portfolio and licensing arrangements thereof. Revenue, classified by timing of recognition, was as follows: Three Months Ended Six Months Ended August 31, 2024 August 31, 2023 August 31, 2024 August 31, 2023 Products and services transferred over time $ 79 $ 79 $ 156 $ 165 Products and services transferred at a point in time 66 53 133 340 Total $ 145 $ 132 $ 289 $ 505 Revenue contract balances The following table sets forth the activity in the Company’s revenue contract balances for the six months ended August 31, 2024: Accounts and Other Receivable Deferred Revenue Deferred Commissions Opening balance as at February 29, 2024 $ 255 $ 222 $ 21 Increases due to invoicing of new or existing contracts, associated contract acquisition costs, or other 272 248 11 Decrease due to payment, fulfillment of performance obligations, or other (317) (281) (12) Decrease, net (45) (33) (1) Closing balance as at August 31, 2024 $ 210 $ 189 $ 20 Transaction price allocated to the remaining performance obligations The table below discloses the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied as at August 31, 2024 and the time frame in which the Company expects to recognize this revenue. The disclosure includes estimates of variable consideration, except when the variable consideration is a sales-based or usage-based royalty promised in exchange for a license of intellectual property. The disclosure excludes estimates of variable consideration relating to potential future royalty revenues from the Malikie Transaction, which have been constrained based on the Company’s accounting policies and critical accounting estimates and as described under “Patent Sale” in this Note 10. As at August 31, 2024 Less than 12 Months 12 to 24 Months Thereafter Total Remaining performance obligations $ 161 $ 13 $ 15 $ 189 Revenue recognized for performance obligations satisfied in prior periods For the three and six months ended August 31, 2024, revenue of $2 million and $2 million respectively, was recognized relating to performance obligations satisfied in a prior period (three and six months ended August 31, 2023 - $1 million and $12 million respectively). Assets by Geography Property, plant and equipment, intangible assets, operating lease ROU assets and goodwill, classified by geographic region in which the Company’s assets are located, were as follows: As at August 31, 2024 February 29, 2024 Property, Plant and Equipment, Intangible Assets, Operating Lease ROU Assets and Goodwill Total Assets Property, Plant and Equipment, Intangible Assets, Operating Lease ROU Assets and Goodwill Total Assets Canada $ 79 $ 323 $ 78 $ 342 United States 640 886 662 923 Other 29 90 29 130 $ 748 $ 1,299 $ 769 $ 1,395 Information About Major Customers

Cash Flow and Additional Inform

Cash Flow and Additional Information	6 Months Ended
	Aug. 31, 2024
Supplemental Cash Flow Information [Abstract]
Cash Flow and Additional Information	CASH FLOW AND ADDITIONAL INFORMATION (a) Certain consolidated statements of cash flow information related to interest and income taxes paid is summarized as follows: Three Months Ended Six Months Ended August 31, 2024 August 31, 2023 August 31, 2024 August 31, 2023 Interest paid during the period $ 2 $ 2 $ 3 $ 3 Income taxes paid during the period 3 2 10 4 Income tax refunds received during the period — — — — (b) Additional Information Foreign exchange The Company is exposed to foreign exchange risk as a result of transactions in currencies other than its functional currency, the U.S. dollar. The majority of the Company’s revenue in the second quarter of fiscal 2025 was transacted in U.S. dollars. Portions of the revenue were denominated in Canadian dollars, euros and British pounds. Other expenses, consisting mainly of salaries and certain other operating costs, were incurred primarily in Canadian dollars, but were also incurred in U.S. dollars, euros and British pounds. At August 31, 2024, approximately 26% of cash and cash equivalents, 26% of accounts receivable and 73% of accounts payable were denominated in foreign currencies (February 29, 2024 – 19%, 25% and 59%, respectively). These foreign currencies primarily include the Canadian dollar, euro and British pound. As part of its risk management strategy, the Company maintains net monetary asset and/or liability balances in foreign currencies and engages in foreign currency hedging activities using derivative financial instruments, including currency forward contracts and currency options. The Company does not use derivative instruments for speculative purposes. Interest rate risk Cash and cash equivalents and investments are invested in certain instruments with fixed interest rates of varying maturities. Consequently, the Company is exposed to interest rate risk as a result of holding investments of varying maturities and the significant financing components within certain revenue contracts with customers. The fair value of investments, as well as the investment income derived from the investment portfolio, will fluctuate with changes in prevailing interest rates. The Company also has significant financing components within certain revenue contracts with customers and is exposed to interest rate risk as a result of discounting the future payments from customers with a fixed interest rate. The Company has also issued Notes with a fixed interest rate, as described in Note 5. The Company is exposed to interest rate risk as a result of the Notes. The Company does not currently utilize interest rate derivative instruments. Credit risk The Company is exposed to market and credit risk on its investment portfolio. The Company is also exposed to credit risk with customers, as described in Note 3. The Company reduces this risk from its investment portfolio by investing in liquid, investment-grade securities and by limiting exposure to any one entity or group of related entities. As at August 31, 2024, no single issuer represented more than 28% of the total cash, cash equivalents and investments (February 29, 2024 - no single issuer represented more than 30% of the total cash, cash equivalents and investments), with the largest such issuer representing bearer deposits, term deposits and cash balances with one of the Company’s banking counterparties. Liquidity risk

Blackberry Limited and Summar_2

Blackberry Limited and Summary of Significant Accounting Policies and Critical Accounting Estimates (Policies)	6 Months Ended
	Aug. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation and preparation	Basis of Presentation and Preparation These interim consolidated financial statements have been prepared by management in accordance with United States generally accepted accounting principles (“U.S. GAAP”). They do not include all of the disclosures required by U.S. GAAP for annual financial statements and should be read in conjunction with the audited consolidated financial statements of BlackBerry Limited (the “Company”) for the year ended February 29, 2024 (the “Annual Financial Statements”), which have been prepared in accordance with U.S. GAAP. In the opinion of management, all normal recurring adjustments considered necessary for fair presentation have been included in these interim consolidated financial statements. Operating results for the three and six months ended August 31, 2024 are not necessarily indicative of the results that may be expected for the full year ending February 28, 2025. The consolidated balance sheet at February 29, 2024 was derived from the audited Annual Financial Statements but does not contain all of the footnote disclosures from the Annual Financial Statements. The preparation of the consolidated financial statements requires management to make estimates and assumptions with respect to the reported amounts of assets, liabilities, revenue and expenses and the disclosure of contingent assets and liabilities. Actual results could differ from these estimates and any such differences may be material to the Company’s consolidated financial statements. Certain of the comparative figures have been reclassified to conform to the current year’s presentation. The Company is organized and managed as three reportable operating segments: Cybersecurity, IoT (collectively, “Software & Services”), and Licensing, as further discussed in Note 10.
Use of estimates	Significant Accounting Policies and Critical Accounting Estimates There have been no material changes to the Company’s accounting policies or critical accounting estimates from those described in the Annual Financial Statements.
New Accounting Pronouncements	Accounting Pronouncements Not Yet Adopted In December 2023, the FASB issued ASU 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” on the topic of income taxes. The standard requires additional disclosure for income taxes. These requirements include: (i) requiring a public entity to disclose specific categories in the rate reconciliation; (ii) disclosure of additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5% of the amount computed by multiplying pretax income or loss by the applicable statutory income tax rate); (iii) annual disclosure of the amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes; (iv) annual disclosure of the amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5% of total income taxes paid (net of refunds received); (v) annual disclosure of income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign; and (vi) annual disclosure of income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. For public entities, the guidance is effective for annual periods beginning after December 15, 2024. The Company will adopt this guidance in fiscal 2026 and is in the process of evaluating the new requirements. As a result, the Company has not yet determined the impact this new ASU will have on its disclosures.

Fair Value Measurements, Cash_2

Fair Value Measurements, Cash, Cash Equivalent and Investments (Tables)	6 Months Ended
	Aug. 31, 2024
Cash and Cash Equivalents [Abstract]
Components of Cash, Cash Equivalents and Investments	The components of cash, cash equivalents and investments by fair value level as at August 31, 2024 were as follows: Cost Basis (1) Unrealized Unrealized Fair Value Cash and Short-term Long-term Restricted Cash and Cash Equivalents Bank balances $ 65 $ — $ — $ 65 $ 65 $ — $ — $ — Other investments 28 6 — 34 — — 34 — 93 6 — 99 65 — 34 — Level 1: Equity securities 10 — (10) — — — — — Level 2: Term deposits, and certificates of deposits 23 — — 23 10 — — 13 Bearer deposit notes 31 — — 31 29 2 — — Commercial paper 44 — — 44 18 26 — — Non-U.S. promissory notes 42 — — 42 30 12 — — U.S. treasury bills 23 — — 23 19 — — 4 163 — — 163 106 40 — 17 Level 3: Other investments 2 1 — 3 — — 3 — $ 268 $ 7 $ (10) $ 265 $ 171 $ 40 $ 37 $ 17 ______________________________ (1) Cost basis for other investments includes the effect of returns of capital and impairment. The components of cash, cash equivalents and investments by fair value level as at February 29, 2024 were as follows: Cost Basis (1) Unrealized Unrealized Fair Value Cash and Short-term Long-term Restricted Cash and Cash Equivalents Bank balances $ 96 $ — $ — $ 96 $ 96 $ — $ — $ — Other investments 30 6 — 36 — — 36 — 126 6 — 132 96 — 36 — Level 1: Equity securities 10 — (10) — — — — — Level 2: Term deposits, and certificates of deposits 21 — — 21 — — — 21 Bearer deposit notes 53 — — 53 28 25 — — Commercial paper 47 — — 47 15 32 — — Non-U.S. promissory notes 35 — — 35 30 5 — — U.S. treasury bills 10 — — 10 6 — — 4 166 — — 166 79 62 — 25 $ 302 $ 6 $ (10) $ 298 $ 175 $ 62 $ 36 $ 25 ______________________________ (1) Cost basis for other investments includes the effect of returns of capital and impairment.
Schedule of Cash and Cash Equivalents	The following table provides a reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents as at August 31, 2024 and February 29, 2024 from the consolidated balance sheets to the consolidated statements of cash flows: As at August 31, 2024 February 29, 2024 Cash and cash equivalents $ 171 $ 175 Restricted cash and cash equivalents 17 25 Total cash, cash equivalents, restricted cash, and restricted cash equivalents presented in the consolidated statements of cash flows $ 188 $ 200
Contractual Maturities of Available-for-Sale Investments	The contractual maturities of available-for-sale investments as at August 31, 2024 and February 29, 2024 were as follows: As at August 31, 2024 February 29, 2024 Cost Basis Fair Value Cost Basis Fair Value Due in one year or less $ 163 $ 163 $ 166 $ 166 No fixed maturity 10 — 10 — $ 173 $ 163 $ 176 $ 166

Consolidated Balance Sheets D_2

Consolidated Balance Sheets Details (Tables)	6 Months Ended
	Aug. 31, 2024
Balance Sheet Related Disclosures [Abstract]
Accounts Receivable, Allowance for Credit Loss	The following table sets forth the activity in the Company’s allowance for credit losses: Carrying Amount Beginning balance as of February 28, 2023 $ 1 Prior period provision for expected credit losses 5 Ending balance of the allowance for credit loss as at February 29, 2024 6 Current period recovery for expected credit losses — Ending balance of the allowance for credit loss as at August 31, 2024 $ 6 The allowance for credit losses as at August 31, 2024 consists of $1 million (February 29, 2024 - $1 million) relating to CECL estimated based on days past due and region and $5 million (February 29, 2024 - $5 million) relating to specific customers that were evaluated separately.
Property, Plant and Equipment	Property, plant and equipment comprised the following: As at August 31, 2024 February 29, 2024 Cost BlackBerry operations and other information technology $ 85 $ 85 Leasehold improvements and other 12 15 Furniture and fixtures 5 6 Manufacturing, repair and research and development equipment 2 3 104 109 Accumulated amortization 87 88 Net book value $ 17 $ 21
Intangible Assets	Intangible assets comprised the following: As at August 31, 2024 Cost Accumulated Net Book Acquired technology $ 900 $ 855 $ 45 Other acquired intangibles 386 341 45 Intellectual property 111 65 46 $ 1,397 $ 1,261 $ 136 As at February 29, 2024 Cost Accumulated Net Book Acquired technology $ 900 $ 846 $ 54 Other acquired intangibles 386 334 52 Intellectual property 111 63 48 $ 1,397 $ 1,243 $ 154
Changes to Carrying Amount of Goodwill	Changes to the carrying amount of goodwill during the six months ended August 31, 2024 were as follows: Carrying Amount Carrying amount as at February 28, 2023 $ 595 Goodwill impairment charge (35) Effect of foreign exchange on non-U.S. dollar denominated goodwill 2 Carrying amount as at February 29, 2024 562 Effect of foreign exchange on non-U.S. dollar denominated goodwill 1 Carrying amount as at August 31, 2024 $ 563
Schedule of Accrued Liabilities	Accrued liabilities is comprised of the following: As at August 31, 2024 February 29, 2024 Variable incentive accrual $ 21 $ 15 Operating lease liabilities, current 17 20 Restructuring program liabilities, current portion 7 20 Other 64 62 $ 109 $ 117
Schedule of Company's Restructuring	The following table sets forth the activity in the Company’s restructuring program liabilities: Employee Facilities Total Balance as at February 28, 2023 2 1 3 Charges incurred 31 6 37 Cash payments made (16) (3) (19) Balance as at February 29, 2024 17 4 21 Charges incurred 7 2 9 Cash payments made (20) (2) (22) Balance as at August 31, 2024 $ 4 $ 4 $ 8 Current portion $ 4 $ 3 $ 7 Long-term portion — 1 1 $ 4 $ 4 $ 8

Debentures (Tables)

Debentures (Tables)	6 Months Ended
	Aug. 31, 2024
Debt Disclosure [Abstract]
Convertible Debt	The following table summarizes the change in the Notes for the six months ended August 31, 2024: Carrying Amount Balance as at February 29, 2024 $ 194 Amortization of debt issuance costs 1 Balance as at August 31, 2024 $ 195
1.75% Debenture - impact of changes in fair value	The following table shows the impact of the changes in fair value of the Debentures for the three and six months ended August 31, 2024 and August 31, 2023: Three Months Ended Six Months Ended August 31, 2024 August 31, 2023 August 31, 2024 August 31, 2023 Income (charge) associated with the change in fair value from non-credit components recorded in the consolidated statements of operations $ — $ 6 $ — $ (16) Total decrease (increase) in the fair value of the 2020 Debentures $ — $ 6 $ — $ (16)

Capital Stock (Tables)

Capital Stock (Tables)	6 Months Ended
	Aug. 31, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract]
Changes in Issued and Outstanding Common Shares	The following details the changes in issued and outstanding common shares for the six months ended August 31, 2024: Capital Stock and Stock Amount Common shares outstanding as at February 29, 2024 589,233 $ 2,948 Common shares issued for restricted share unit settlements 940 — Stock-based compensation — 15 Common shares issued for employee share purchase plan 555 1 Common shares outstanding as at August 31, 2024 590,728 $ 2,964

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	6 Months Ended
	Aug. 31, 2024
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Earnings Per Share	The following table sets forth the computation of basic and diluted loss per share: Three Months Ended Six Months Ended August 31, 2024 August 31, 2023 August 31, 2024 August 31, 2023 Net loss for basic and diluted loss per share available to common shareholders $ (19) $ (42) $ (61) $ (53) Weighted average number of shares outstanding (000’s) - basic and diluted (1)(2) 590,549 583,524 590,188 583,171 Loss per share - reported Basic $ (0.03) $ (0.07) $ (0.10) $ (0.09) Diluted $ (0.03) $ (0.07) $ (0.10) $ (0.09) ______________________________ (1) The Company has not presented the dilutive effect of the Notes or 2020 Debentures using the if-converted method in the calculation of diluted loss per share for the three and six months ended August 31, 2024 and August 31, 2023, as to do so would be antidilutive. See Note 5 for details on the Notes and 2020 Debentures. (2) The Company has not presented the dilutive effect of in-the-money options and RSUs that will be settled upon vesting by the issuance of new common shares in the calculation of diluted loss per share for the three and six months ended August 31, 2024 and August 31, 2023, as to do so would be antidilutive.

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	6 Months Ended
	Aug. 31, 2024
Equity [Abstract]
Components of Accumulated Other Comprehensive Loss	The changes in AOCL by component net of tax, for the three and six months ended August 31, 2024 and August 31, 2023 were as follows: Three Months Ended Six Months Ended August 31, 2024 August 31, 2023 August 31, 2024 August 31, 2023 Cash Flow Hedges Balance, beginning of period $ — $ — $ — $ (1) Amounts reclassified from AOCL into net loss — — — 1 Accumulated net unrealized gains on derivative instruments designated as cash flow hedges $ — $ — $ — $ — Foreign Currency Cumulative Translation Adjustment Balance, beginning of period $ (15) $ (15) $ (14) $ (16) Other comprehensive income 2 1 1 2 Foreign currency cumulative translation adjustment $ (13) $ (14) $ (13) $ (14) Change in Fair Value From Instrument-Specific Credit Risk On Debentures Change in fair value from instruments-specific credit risk on Debentures $ — $ (6) $ — $ (6) Other Post-Employment Benefit Obligations Actuarial losses associated with other post-employment benefit obligations $ — $ (1) $ — $ (1) Accumulated Other Comprehensive Loss, End of Period $ (13) $ (21) $ (13) $ (21)

Revenue and Segment Disclosure

Revenue and Segment Disclosure (Tables)	6 Months Ended
	Aug. 31, 2024
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment	The following table shows information by operating segment for the three and six months ended August 31, 2024 and August 31, 2023: For the Three Months Ended Cybersecurity IoT Licensing Segment Totals August 31, August 31, August 31, August 31, 2024 2023 2024 2023 2024 2023 2024 2023 Segment revenue $ 87 $ 79 $ 55 $ 49 $ 3 $ 4 $ 145 $ 132 Segment cost of sales 39 36 10 8 1 2 50 46 Segment gross margin (1) $ 48 $ 43 $ 45 $ 41 $ 2 $ 2 $ 95 $ 86 For the Six Months Ended Cybersecurity IoT Licensing Segment Totals August 31, August 31, August 31, August 31, 2024 2023 2024 2023 2024 2023 2024 2023 Segment revenue $ 172 $ 172 $ 108 $ 94 $ 9 $ 239 $ 289 $ 505 Segment cost of sales 74 73 20 17 3 149 97 239 Segment gross margin (1) $ 98 $ 99 $ 88 $ 77 $ 6 $ 90 $ 192 $ 266 ______________________________ (1) A reconciliation of total segment gross margin to consolidated totals is set forth below.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated	The following table reconciles total segment gross margin for the three and six months ended August 31, 2024 and August 31, 2023 to the Company’s consolidated totals: Three Months Ended Six Months Ended August 31, 2024 August 31, 2023 August 31, 2024 August 31, 2023 Total segment gross margin $ 95 $ 86 192 $ 266 Adjustments (1) : Less: Stock compensation 1 1 2 2 Less: Research & development 37 50 79 104 Sales and marketing 34 43 72 88 General and administrative 33 30 73 84 Amortization 11 14 23 29 Impairment of long-lived assets — 1 3 1 Debentures fair value adjustment — (6) — 16 Investment income, net (3) (7) (8) (10) Loss before income taxes $ (18) $ (40) $ (52) $ (48) ______________________________ (1) The CODM reviews segment information on an adjusted basis, which excludes certain amounts as described below: Stock compensation expenses - Equity compensation is a non-cash expense and does not impact the ongoing operating decisions taken by the Company’s management.
Revenue from External Customers by Geographic Areas	The Company’s revenue, classified by major geographic region in which the Company’s customers are located, was as follows: Three Months Ended Six Months Ended August 31, 2024 August 31, 2023 August 31, 2024 August 31, 2023 North America (1) $ 69 $ 72 $ 137 $ 389 Europe, Middle East and Africa 47 39 94 76 Other regions 29 21 58 40 Total $ 145 $ 132 $ 289 $ 505 North America (1) 47.6 % 54.5 % 47.4 % 77.0 % Europe, Middle East and Africa 32.4 % 29.6 % 32.5 % 15.1 % Other regions 20.0 % 15.9 % 20.1 % 7.9 % Total 100.0 % 100.0 % 100.0 % 100.0 % ______________________________ (1) North America includes all revenue from the Company’s intellectual property arrangements, due to the global applicability of the patent portfolio and licensing arrangements thereof.
Revenue Classified by Timing of Recognition	Revenue, classified by timing of recognition, was as follows: Three Months Ended Six Months Ended August 31, 2024 August 31, 2023 August 31, 2024 August 31, 2023 Products and services transferred over time $ 79 $ 79 $ 156 $ 165 Products and services transferred at a point in time 66 53 133 340 Total $ 145 $ 132 $ 289 $ 505
Revenue Contract Balances	The following table sets forth the activity in the Company’s revenue contract balances for the six months ended August 31, 2024: Accounts and Other Receivable Deferred Revenue Deferred Commissions Opening balance as at February 29, 2024 $ 255 $ 222 $ 21 Increases due to invoicing of new or existing contracts, associated contract acquisition costs, or other 272 248 11 Decrease due to payment, fulfillment of performance obligations, or other (317) (281) (12) Decrease, net (45) (33) (1) Closing balance as at August 31, 2024 $ 210 $ 189 $ 20
Transaction Price Allocated to the Remaining Performance Obligation	The table below discloses the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied as at August 31, 2024 and the time frame in which the Company expects to recognize this revenue. The disclosure includes estimates of variable consideration, except when the variable consideration is a sales-based or usage-based royalty promised in exchange for a license of intellectual property. The disclosure excludes estimates of variable consideration relating to potential future royalty revenues from the Malikie Transaction, which have been constrained based on the Company’s accounting policies and critical accounting estimates and as described under “Patent Sale” in this Note 10. As at August 31, 2024 Less than 12 Months 12 to 24 Months Thereafter Total Remaining performance obligations $ 161 $ 13 $ 15 $ 189
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas	Property, plant and equipment, intangible assets, operating lease ROU assets and goodwill, classified by geographic region in which the Company’s assets are located, were as follows: As at August 31, 2024 February 29, 2024 Property, Plant and Equipment, Intangible Assets, Operating Lease ROU Assets and Goodwill Total Assets Property, Plant and Equipment, Intangible Assets, Operating Lease ROU Assets and Goodwill Total Assets Canada $ 79 $ 323 $ 78 $ 342 United States 640 886 662 923 Other 29 90 29 130 $ 748 $ 1,299 $ 769 $ 1,395

Cash Flow and Additional Info_2

Cash Flow and Additional Information (Tables)	6 Months Ended
	Aug. 31, 2024
Supplemental Cash Flow Information [Abstract]
Supplemental Cash Flow Information	(a) Certain consolidated statements of cash flow information related to interest and income taxes paid is summarized as follows: Three Months Ended Six Months Ended August 31, 2024 August 31, 2023 August 31, 2024 August 31, 2023 Interest paid during the period $ 2 $ 2 $ 3 $ 3 Income taxes paid during the period 3 2 10 4 Income tax refunds received during the period — — — —

Fair Value Measurements - Non-R

Fair Value Measurements - Non-Recurring Fair Value Measurements (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impairment of long-lived assets (note 2)	$ 0	$ 1	$ 3	$ 1
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount	$ 0		$ 1

Cash, Cash Equivalents and Inve

Cash, Cash Equivalents and Investments - Components of Cash, Cash Equivalents and Investments (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Aug. 31, 2024		Aug. 31, 2024		Feb. 29, 2024
Cash, Cash Equivalents and Investments [Line Items]
Cost Basis	$ 268		$ 268		$ 302
Unrealized Gains			7		6
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount	0		1
Unrealized Losses			(10)		(10)
Fair Value	265		265		298
Cash and cash equivalents (note 2)	171		171		175
Short-term Investments	40		40		62
Long-term investments (note 2)	37		37		36
Restricted Cash and Cash Equivalents	17		17		25
Bank balances
Cash, Cash Equivalents and Investments [Line Items]
Cost Basis	65		65		96
Unrealized Gains			0		0
Unrealized Losses			0		0
Fair Value	65		65		96
Cash and cash equivalents (note 2)	65		65		96
Short-term Investments	0		0		0
Long-term investments (note 2)	0		0		0
Restricted Cash and Cash Equivalents	0		0		0
Other investments
Cash, Cash Equivalents and Investments [Line Items]
Cost Basis	28	[1]	28	[1]	30	[2]
Unrealized Gains			6		6
Unrealized Losses			0		0
Fair Value	34		34		36
Cash and cash equivalents (note 2)	0		0		0
Short-term Investments	0		0		0
Long-term investments (note 2)	34		34		36
Restricted Cash and Cash Equivalents	0		0		0
Bank Balances and Other Investments [Domain]
Cash, Cash Equivalents and Investments [Line Items]
Cost Basis	93		93		126
Unrealized Gains			6		6
Unrealized Losses			0		0
Fair Value	99		99		132
Cash and cash equivalents (note 2)	65		65		96
Short-term Investments	0		0		0
Long-term investments (note 2)	34		34		36
Restricted Cash and Cash Equivalents	0		0		0
Level 1: | Equity securities
Cash, Cash Equivalents and Investments [Line Items]
Cost Basis	10		10		10
Equity Securities, FV-NI, Unrealized Gain			0		0
Equity Securities, FV-NI, Unrealized Loss			(10)		(10)
Fair Value	0		0		0
Cash and cash equivalents (note 2)	0		0		0
Short-term Investments	0		0		0
Long-term investments (note 2)	0		0		0
Restricted Cash and Cash Equivalents	0		0		0
Level 2:
Cash, Cash Equivalents and Investments [Line Items]
Cost Basis	163		163		166
Debt Securities, Available-for-Sale, Unrealized Gain			0		0
Debt Securities, Available-for-Sale, Unrealized Loss			0		0
Fair Value	163		163		166
Cash and cash equivalents (note 2)	106		106		79
Short-term Investments	40		40		62
Long-term investments (note 2)	0		0		0
Restricted Cash and Cash Equivalents	17		17		25
Level 2: | Term deposits, and certificates of deposits
Cash, Cash Equivalents and Investments [Line Items]
Cost Basis	23		23		21
Debt Securities, Available-for-Sale, Unrealized Gain			0		0
Debt Securities, Available-for-Sale, Unrealized Loss			0		0
Fair Value	23		23		21
Cash and cash equivalents (note 2)	10		10		0
Short-term Investments	0		0		0
Long-term investments (note 2)	0		0		0
Restricted Cash and Cash Equivalents	13		13		21
Level 2: | Bearer deposit notes
Cash, Cash Equivalents and Investments [Line Items]
Cost Basis	31		31		53
Debt Securities, Available-for-Sale, Unrealized Gain			0		0
Debt Securities, Available-for-Sale, Unrealized Loss			0		0
Fair Value	31		31		53
Cash and cash equivalents (note 2)	29		29		28
Short-term Investments	2		2		25
Long-term investments (note 2)	0		0		0
Restricted Cash and Cash Equivalents	0		0		0
Level 2: | Commercial paper
Cash, Cash Equivalents and Investments [Line Items]
Cost Basis	44		44		47
Debt Securities, Available-for-Sale, Unrealized Gain			0		0
Debt Securities, Available-for-Sale, Unrealized Loss			0		0
Fair Value	44		44		47
Cash and cash equivalents (note 2)	18		18		15
Short-term Investments	26		26		32
Long-term investments (note 2)	0		0		0
Restricted Cash and Cash Equivalents	0		0		0
Level 2: | Non-U.S. promissory notes
Cash, Cash Equivalents and Investments [Line Items]
Cost Basis	42		42		35
Debt Securities, Available-for-Sale, Unrealized Gain			0		0
Debt Securities, Available-for-Sale, Unrealized Loss			0		0
Fair Value	42		42		35
Cash and cash equivalents (note 2)	30		30		30
Short-term Investments	12		12		5
Long-term investments (note 2)	0		0		0
Restricted Cash and Cash Equivalents	0		0		0
Level 2: | U.S. treasury bills
Cash, Cash Equivalents and Investments [Line Items]
Cost Basis	23		23		10
Unrealized Gains			0		0
Unrealized Losses			0		0
Fair Value	23		23		10
Cash and cash equivalents (note 2)	19		19		6
Short-term Investments	0		0		0
Long-term investments (note 2)	0		0		0
Restricted Cash and Cash Equivalents	4		4		$ 4
Level 3: | Other investments
Cash, Cash Equivalents and Investments [Line Items]
Cost Basis	2		2
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount			1
Unrealized Losses			0
Fair Value	3		3
Cash and cash equivalents (note 2)	0		0
Short-term Investments	0		0
Long-term investments (note 2)	3		3
Restricted Cash and Cash Equivalents	$ 0		$ 0
[1]Cost basis for other investments includes the effect of returns of capital and impairment.[2]Cost basis for other investments includes the effect of returns of capital and impairment.

Cash, Cash Equivalents and In_2

Cash, Cash Equivalents and Investments - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023	Feb. 29, 2024
Cash, Cash Equivalents and Investments [Line Items]
Investments that are communicated to the third party for consideration of reasonableness, threshold limit for fair values			0.50%
Equity Securities without Readily Determinable Fair Value, Amount	$ 37		$ 37		$ 36
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount	0		1
Debt Securities, Available-for-sale, Realized Gain (Loss)	0	$ 0	0	$ 0
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	0		0		0
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount	$ 3		$ 3		$ 3
Minimum
Cash, Cash Equivalents and Investments [Line Items]
Letters of credit terms			1 month
Maximum
Cash, Cash Equivalents and Investments [Line Items]
Letters of credit terms			4 years

Cash, Cash Equivalent, Restrict

Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent Presented in the Consolidated Statements of Cash Flow (Details) - USD ($) $ in Millions	Aug. 31, 2024	Feb. 29, 2024	Aug. 31, 2023	Feb. 28, 2023
Cash and Cash Equivalents [Abstract]
Cash and cash equivalents (note 2)	$ 171	$ 175
Restricted Cash and Cash Equivalents	17	25
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total	$ 188	$ 200	$ 443	$ 322

Cash, Cash Equivalents and In_3

Cash, Cash Equivalents and Investments - Contractual Maturities of Available-for-Sale Investments (Details) - USD ($) $ in Millions	Aug. 31, 2024	Feb. 29, 2024
Cost Basis
Due in one year or less	$ 163	$ 166
No fixed maturity	10	10
Total	173	176
Fair Value
Due in one year or less	163	166
No fixed maturity	0	0
Total	$ 163	$ 166

Consolidated Balance Sheets D_3

Consolidated Balance Sheets Details - Accounts Receivable (Details) $ in Millions	6 Months Ended	12 Months Ended
	Aug. 31, 2024 USD ($)	Feb. 29, 2024 USD ($)
Balance Sheet Related Disclosures [Abstract]
Accounts Receivable, Allowance for Credit Loss, Relating to CECL Estimated Based on Days Past Due and Region	$ 1	$ 1
Accounts Receivable, Allowance for Credit Loss, Relating to Customers Evaluated Separately	$ 5	$ 5
Number of customers with a balance greater than 10% of total accounts receivable	1	2
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Accounts Receivable, Allowance for Credit Loss, Beginning Balance	$ 6	$ 1
Current period recovery for expected credit losses	0	5
Accounts Receivable, Allowance for Credit Loss, Ending Balance	$ 6	$ 6

Consolidated Balance Sheets D_4

Consolidated Balance Sheets Details - Other Current Assets (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Aug. 31, 2024	Feb. 29, 2024
Condensed Balance Sheet Statements, Captions [Line Items]
Other current assets (note 3)	$ 52	$ 47
Other current assets greater than five percent of current assets	none	none
Other Long-Term Assets Greater than Five Percent of Total Assets	none	none

Consolidated Balance Sheets D_5

Consolidated Balance Sheets Detail - Property, Plant and Equipment (Details) - USD ($) $ in Millions	Aug. 31, 2024	Feb. 29, 2024
Property, Plant and Equipment [Line Items]
Cost of property, plant and equipment	$ 104	$ 109
Accumulated amortization	87	88
Net book value	17	21
BlackBerry operations and other information technology
Property, Plant and Equipment [Line Items]
Cost of property, plant and equipment	85	85
Leasehold improvements and other
Property, Plant and Equipment [Line Items]
Cost of property, plant and equipment	12	15
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Cost of property, plant and equipment	5	6
Manufacturing, repair and research and development equipment
Property, Plant and Equipment [Line Items]
Cost of property, plant and equipment	$ 2	$ 3

Consolidated Balance Sheets D_6

Consolidated Balance Sheets Detail - Intangible Assets (Details) - USD ($) $ in Millions	6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Feb. 29, 2024
Finite-Lived Intangible Assets [Line Items]
Cost	$ 1,397		$ 1,397
Accumulated Amortization	1,261		1,243
Net Book Value	136		154
Amortization expenses related to intangible assets	22	$ 26
Payments to Acquire Intangible Assets	4	$ 10
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2025	21
2026	37
2027	32
2028	18
2029	6
2030	3
Acquired technology
Finite-Lived Intangible Assets [Line Items]
Cost	900		900
Accumulated Amortization	855		846
Net Book Value	45		54
Other acquired intangibles
Finite-Lived Intangible Assets [Line Items]
Cost	386		386
Accumulated Amortization	341		334
Net Book Value	45		52
Intellectual property
Finite-Lived Intangible Assets [Line Items]
Cost	111		111
Accumulated Amortization	65		63
Net Book Value	$ 46		$ 48

Consolidated Balance Sheets D_7

Consolidated Balance Sheets Details Consolidated Balance Sheet Details - Changes to Carrying Amount of Goodwill (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Aug. 31, 2024	Feb. 29, 2024
Goodwill [Roll Forward]
Carrying amount as of beginning of period	$ 562	$ 595
Impairment of goodwill		35
Effect of foreign exchange on non-U.S. dollar denominated goodwill	1	2
Carrying amount as of end of period	$ 563	$ 562

Consolidated Balance Sheets D_8

Consolidated Balance Sheets Detail - Accrued Liabilities (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Aug. 31, 2024	Feb. 29, 2024
Balance Sheet Related Disclosures [Abstract]
Variable incentive accrual	$ 21	$ 15
Operating lease liabilities, current (included in accruals)	17	20
Restructuring Reserve, Current	7	20
Other	64	62
Accrued liabilities total	$ 109	$ 117
Other accrued liabilities greater than five percent of current liabilities	none	none

Consolidated Balance Sheets D_9

Consolidated Balance Sheets Detail - Additional Information (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Aug. 31, 2024	Feb. 29, 2024
Accrued Liabilities
Other Receivables Greater than Five Percent of Current Assets	none	none
Other accrued liabilities greater than five percent of current liabilities	none	none
Other	$ 64	$ 62

Consolidated Balance Sheets _10

Consolidated Balance Sheets Details (Details) - Restructuring - USD ($) $ in Millions	6 Months Ended		12 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Feb. 29, 2024	Feb. 28, 2023
Restructuring Cost and Reserve
Restructuring reserve	$ 8		$ 21	$ 3
Charges incurred	9	$ 8	37
Payments for Restructuring	22		19
Restructuring Reserve, Current	7		20
Restructuring Reserve, Noncurrent	$ 1
Interest rate to present value long-term restructuring liability	5.30%
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]	General and Administrative Expense
Employee Termination Benefits
Restructuring Cost and Reserve
Restructuring reserve	$ 4		17	2
Charges incurred	7		31
Payments for Restructuring	20		16
Restructuring Reserve, Current	4
Restructuring Reserve, Noncurrent	0
Facilities Costs
Restructuring Cost and Reserve
Restructuring reserve	4		4	$ 1
Charges incurred	2		6
Payments for Restructuring	2		$ 3
Restructuring Reserve, Current	3
Restructuring Reserve, Noncurrent	$ 1

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Millions	6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Feb. 29, 2024
Income Tax Disclosure [Abstract]
Effective Income Recovery (Expense) Tax Rate Reconciliation, Percent	(17.00%)	(10.00%)
Unrecognized Tax Benefits	$ 20		$ 20
Unrecognized tax benefits netted against deferred income taxes	20
Unrecognized tax benefits included within taxes payable	$ 0

Debentures (Details)

Debentures (Details) $ / shares in Units, shares in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Aug. 31, 2024 USD ($) $ / shares	Aug. 31, 2023 USD ($)	Aug. 31, 2024 USD ($) $ / shares shares	Aug. 31, 2023 USD ($)	Feb. 29, 2024 USD ($)	Nov. 13, 2023 USD ($)
Debt Instrument [Line Items]
Redemption period, end date			Feb. 15, 2029
Par value of convertible debentures			$ 1,000
Interest expense, debt	$ 2,000,000	$ 2,000,000	3,000,000	$ 3,000,000
Long-term notes (note 5)	195,000,000		195,000,000		$ 194,000,000
Related Party Principal Amounts of 2020 Debenture Owned	330,000,000		330,000,000
2020 Debentures
Debt Instrument [Line Items]
Face amount of debt						$ 365,000,000
Redemption period, end date					Nov. 13, 2023
Senior Convertible Notes
Debt Instrument [Line Items]
Face amount of debt	200,000,000		200,000,000		$ 194,000,000
Amortization of Debt Issuance Costs			1,000,000
Long-Term Debt	$ 195,000,000		$ 195,000,000
Interest rate	3%		3%
Debt Instrument, Convertible, Number of Equity Instruments - with decimals			257.5826
Conversion of stock (in shares) | shares			52,000
Conversion price (in dollars per share) | $ / shares	$ 3.88		$ 3.88
Date of first interest payment			Aug. 15, 2024
Debt Instrument, Interest Rate Terms			The Notes bear interest at a rate of 3.00% per annum, payable semi-annually in arrears on February 15 and August 15 of each year, beginning on August 15, 2024
Payments of Debt Issuance Costs			$ 6,000,000

Debentures - Change in Fair Val

Debentures - Change in Fair Value (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Debt Instrument [Line Items]
Debenture, Fair Value, beginning balance			$ 194
Debenture total fair value adjustment			0
Debenture, Fair Value, ending balance	$ 195		$ 195
2020 Debentures
Debt Instrument [Line Items]
Debenture total fair value adjustment	$ 0	$ (6)		$ 16

Debentures - Impact of Changes

Debentures - Impact of Changes in Fair Value of Debentures (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Debt Instrument [Line Items]
Income (charge) associated with the change in fair value from non-credit components recorded in the consolidated statements of operations	$ 0	$ 6	$ 0	$ (16)
Debenture total fair value adjustment			0
2020 Debentures
Debt Instrument [Line Items]
Income (charge) associated with the change in fair value from non-credit components recorded in the consolidated statements of operations	0	6	$ 0	(16)
Debenture total fair value adjustment	$ 0	$ 6		$ (16)

Capital Stock - Changes in Issu

Capital Stock - Changes in Issued and Outstanding Common Shares (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Common Stock [Roll Forward]
Capital stock outstanding, Shares, Beginning Balance			589,232,539
Capital stock outstanding, Shares, Ending Balance	590,727,996		590,727,996
Common Stock, Amount [Roll Forward]
Stock-based compensation	$ 7	$ 11	$ 15	$ 20
Employee share purchase plan			$ 1	2
Capital Stock and Additional Paid-in Capital
Common Stock [Roll Forward]
Capital stock outstanding, Shares, Beginning Balance			589,233,000
Common shares issued for restricted share unit settlements			940,000
Common shares issued for employee share purchase plan			555,000
Capital stock outstanding, Shares, Ending Balance	590,728,000		590,728,000
Common Stock, Amount [Roll Forward]
Common Stock, Value, Outstanding			$ 2,948
Stock-based compensation	$ 7	$ 11	15	20
Employee share purchase plan			1	$ 2
Common Stock, Value, Outstanding	$ 2,964		$ 2,964

Capital Stock - Subsequent even

Capital Stock - Subsequent event (Details) - shares	6 Months Ended
	Aug. 31, 2024	Sep. 24, 2024	Feb. 29, 2024
Equity [Abstract]
Common outstanding (in shares)	590,727,996		589,232,539
Class of Stock [Line Items]
Common outstanding (in shares)	590,727,996		589,232,539
1.75% Debenture
Class of Stock [Line Items]
Conversion of stock (in shares)	51,500,000
Voting Common Stock [Member] | Subsequent Event [Member]
Equity [Abstract]
Common outstanding (in shares)		591,000,000
Class of Stock [Line Items]
Common outstanding (in shares)		591,000,000
Employee Stock Option [Member] | Subsequent Event [Member]
Equity [Abstract]
Common outstanding (in shares)		200,000
Class of Stock [Line Items]
Common outstanding (in shares)		200,000
Restricted Share Units (RSUs) | Subsequent Event [Member]
Equity [Abstract]
Common outstanding (in shares)		18,000,000
Class of Stock [Line Items]
Common outstanding (in shares)		18,000,000
Deferred Share Unit | Subsequent Event [Member]
Equity [Abstract]
Common outstanding (in shares)		1,000,000
Class of Stock [Line Items]
Common outstanding (in shares)		1,000,000

Earnings (Loss) Per Share - Sum

Earnings (Loss) Per Share - Summary of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions		3 Months Ended		6 Months Ended
		Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Earnings Per Share [Abstract]
Net loss for basic and diluted loss per share available to common shareholders		$ (19)	$ (42)	$ (61)	$ (53)
Weighted-average number of shares outstanding (000's) - basic and diluted (in shares)	[1],[2]	590,549	583,524	590,188	583,171
Earnings (Loss) Per Share, Basic (in usd per share)		$ (0.03)	$ (0.07)	$ (0.10)	$ (0.09)
Earnings (Loss) Per Share, Diluted (in usd per share)		$ (0.03)	$ (0.07)	$ (0.10)	$ (0.09)
[1] The Company has not presented the dilutive effect of in-the-money options and RSUs that will be settled upon vesting by the issuance of new common shares in the calculation of diluted loss per share for the three and six months ended August 31, 2024 and August 31, 2023, as to do so would be antidilutive.

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	$ 742	$ 859	$ 776	$ 857
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	2	1	1	2
Ending Balance	732	829	732	829
Cash Flow Hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	0	0	0	(1)
Amounts reclassified from AOCL into net loss	0	0	0	1
Ending Balance	0	0	0	0
Foreign Currency Cumulative Translation Adjustment
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	(15)	(15)	(14)	(16)
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	2	1	1	2
Ending Balance	(13)	(14)	(13)	(14)
Change in Fair Value From Instrument-Specific Credit Risk On Debentures
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Ending Balance	0	(6)	0	(6)
Other Post-Employment Benefit Obligations
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Ending Balance	0	(1)	0	(1)
AOCI Attributable to Parent
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Ending Balance	$ (13)	$ (21)	$ (13)	$ (21)

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions	Aug. 31, 2024	Feb. 29, 2024
Loss Contingencies Line Items]
Collateral of outstanding letters of credit	$ 16
Funds from claim filed with Ministry of Innovation, Science and Economic Development Canada relating to Strategic Innovation Fund Program	$ 17	$ 17

Revenue and Segment Disclosur_2

Revenue and Segment Disclosures - Operating results by operating segments (Details) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2024 USD ($)	Aug. 31, 2023 USD ($)	Aug. 31, 2024 USD ($) operatingSegment	Aug. 31, 2023 USD ($)
Segment Reporting [Abstract]
Number of Operating Segments | operatingSegment			3
Segment Reporting Information [Line Items]
Revenues	$ 145	$ 132	$ 289	$ 505
Cost of sales	51	47	99	241
Segment gross margin	94	85	190	264
Cybersecurity
Segment Reporting Information [Line Items]
Revenues	87	79	172	172
Cost of sales	39	36	74	73
Segment gross margin	48	43	98	99
IoT
Segment Reporting Information [Line Items]
Revenues	55	49	108	94
Cost of sales	10	8	20	17
Segment gross margin	45	41	88	77
Licensing
Segment Reporting Information [Line Items]
Revenues	3	4	9	239
Cost of sales	1	2	3	149
Segment gross margin			6
Segment gross margin	2	2		90
Total Operating Segments
Segment Reporting Information [Line Items]
Revenues	145	132	289	505
Cost of sales	50	46	97	239
Segment gross margin	$ 95	$ 86	$ 192	$ 266

Revenue and Segment Disclosur_3

Revenue and Segment Disclosures - Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details) - USD ($) $ in Millions		3 Months Ended		6 Months Ended
		Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Segment gross margin		$ 94	$ 85	$ 190	$ 264
Cost of sales		51	47	99	241
Research and development		37	50	79	104
Selling and Marketing Expense		34	43	72	88
General and Administrative Expense		33	30	73	84
Amortization		11	14	23	29
Impairment of long-lived assets (note 2)		0	1	3	1
Debentures fair value adjustment		0	(6)	0	16
Investment income, net (note 2 and note 5)		3	7	8	10
Loss before income taxes		(18)	(40)	(52)	(48)
Total Operating Segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Segment gross margin		95	86	192	266
Cost of sales		50	46	97	239
Segment Reconciling Items
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Cost of sales	[1]	1	1	2	2
Investment income, net (note 2 and note 5)		$ 3	$ 7	$ 8	$ 10
[1]The CODM reviews segment information on an adjusted basis, which excludes certain amounts as described below: Stock compensation expenses - Equity compensation is a non-cash expense and does not impact the ongoing operating decisions taken by the Company’s management.

Revenue and Segment Disclosur_4

Revenue and Segment Disclosures (Details) - Additional Details - USD ($) $ in Millions	6 Months Ended		12 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Feb. 29, 2024	May 11, 2023
Segment Reporting [Abstract]
Patent sale cash consideration on closing				$ 170
Patent sale consideration no later than third anniversary date of closing				30
Patent sale consideration in the form of potential future royalty				$ 700
Revenue recognized on patent sale			$ 218
Patent sale financing component	$ 8
Patent sale variable consideration recognized on sale			23
Patent sale variable consideration constrained			210
Intellectual property disposed of by sale	$ 0	$ 147	$ 147

Revenue and Segment Disclosur_5

Revenue and Segment Disclosures - Revenue from External Customers by Geographic Areas (Details) - USD ($) $ in Millions		3 Months Ended		6 Months Ended
		Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Segment Reporting Information [Line Items]
Total Revenue		$ 145	$ 132	$ 289	$ 505
Total Revenue Rate		100%	100%	100%	100%
Number of customers that comprised more than 10% of total revenue		one	no	one	one
Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | One Customer
Segment Reporting Information [Line Items]
Concentration risk, percentage		11%	10%	12%	45%
North America
Segment Reporting Information [Line Items]
Total Revenue	[1]	$ 69	$ 72	$ 137	$ 389
Total Revenue Rate	[1]	47.60%	54.50%	47.40%	77%
Europe, Middle East and Africa
Segment Reporting Information [Line Items]
Total Revenue		$ 47	$ 39	$ 94	$ 76
Total Revenue Rate		32.40%	29.60%	32.50%	15.10%
Other regions
Segment Reporting Information [Line Items]
Total Revenue		$ 29	$ 21	$ 58	$ 40
Total Revenue Rate		20%	15.90%	20.10%	7.90%
[1]North America includes all revenue from the Company’s intellectual property arrangements, due to the global applicability of the patent portfolio and licensing arrangements thereof

Revenue and Segment Disclosur_6

Revenue and Segment Disclosures Revenue classified by timing of recognition (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Revenue classified by timing of recognition [Line Items]
Revenues	$ 145	$ 132	$ 289	$ 505
Products and services transferred over time
Revenue classified by timing of recognition [Line Items]
Revenues	79	79	156	165
Products and services transferred at a point in time
Revenue classified by timing of recognition [Line Items]
Revenues	$ 66	$ 53	$ 133	$ 340

Revenue and Segment Disclosur_7

Revenue and Segment Disclosures Revenue Contract Balances (Details) - USD ($) $ in Millions	6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Revenue Contract Balances [Line Items]
Increase (Decrease) in Deferred Revenue	$ (33)	$ (20)
Accounts and Other Receivable
Revenue Contract Balances [Line Items]
Contract with Customer, Asset, Net - Current and Non-Current	255
Increase in contract receivable	272
Decrease in contract asset	(317)
Increase (Decrease) In Contract Assets	(45)
Contract with Customer, Asset, Net - Current and Non-Current	210
Deferred Revenue
Revenue Contract Balances [Line Items]
Deferred Revenue	222
Deferred Revenue, Additions	248
Decrease due to payment, fulfillment of performance obligations, or other	(281)
Increase (Decrease) in Deferred Revenue	(33)
Deferred Revenue	189
Deferred Commissions
Revenue Contract Balances [Line Items]
Capitalized Contract Cost, Net	21
Increase in deferred commission	11
Decrease in deferred commission	(12)
Net change in deferred commission	(1)
Capitalized Contract Cost, Net	$ 20

Revenue and Segment Disclosur_8

Revenue and Segment Disclosures -Transaction price allocated to the remaining performance obligations (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Transaction price allocated to the remaining performance obligations [Line Items]
Contract with Customer, Performance Obligation Satisfied in Previous Period	$ 2	$ 1	$ 2	$ 12
Revenue, Remaining Performance Obligation, Amount	189		189
Less than 12 months
Transaction price allocated to the remaining performance obligations [Line Items]
Revenue, Remaining Performance Obligation, Amount	161		161
12 to 24 months
Transaction price allocated to the remaining performance obligations [Line Items]
Revenue, Remaining Performance Obligation, Amount	13		13
After 24 months
Transaction price allocated to the remaining performance obligations [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 15		$ 15

Revenue and Segment Disclosur_9

Revenue and Segment Disclosures - Long-lived Assets and Total Assets by Geographic Areas (Details) - USD ($) $ in Millions	Aug. 31, 2024	Feb. 29, 2024
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	$ 748	$ 769
Assets	1,299	1,395
Canada
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	79	78
Assets	323	342
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	640	662
Assets	886	923
Other Countries
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	29	29
Assets	$ 90	$ 130

Cash Flow and Additional Info_3

Cash Flow and Additional Information - Interest and Income Taxes Paid (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Supplemental Cash Flow Information [Abstract]
Interest paid during the period	$ 2	$ 2	$ 3	$ 3
Income taxes paid during the period	3	2	10	4
Income tax refunds received during the period	$ 0	$ 0	$ 0	$ 0

Additional Information - Additi

Additional Information - Additional Information (Details) - USD ($) $ in Millions	Aug. 31, 2024	Feb. 29, 2024
Supplemental Cash Flow Information [Abstract]
Percentage of cash and cash equivalents denominated in foreign currencies	26%	19%
Percentage of accounts receivable denominated in foreign currencies	26%	25%
Percentage of accounts payable denominated in foreign currencies	73%	59%
Percentage of cash, cash equivalents and investments threshold used to determine major issuer	28%	30%
Cash, Cash Equivalents And Investments	$ 265	$ 298